Concentric Analgesics Revenue and Competitors

Location

$20M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Concentric Analgesics's estimated annual revenue is currently $5.7M per year.(i)
  • Concentric Analgesics's estimated revenue per employee is $155,000
  • Concentric Analgesics's total funding is $20M.

Employee Data

  • Concentric Analgesics has 37 Employees.(i)
  • Concentric Analgesics grew their employee count by 28% last year.

Concentric Analgesics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Co-Founder (VP - Chemistry)Reveal Email/Phone
3
Head Clinical OperationsReveal Email/Phone
4
EVP, DevelopmentReveal Email/Phone
5
Director, Regulatory AffairsReveal Email/Phone
6
President and Chief Scientific OfficerReveal Email/Phone
7
Senior DirectorReveal Email/Phone
8
Associate Director, Clinical OperationsReveal Email/Phone
9
Bioanalytical ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Concentric Analgesics?

Concentric Analgesics, Inc. is a private, biotechnology company focused on discovering and developing novel, non-opioid therapeutics for the management of acute and chronic pain.

keywords:N/A

$20M

Total Funding

37

Number of Employees

$5.7M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Concentric Analgesics News

2022-04-06 - Clinical Catch-Up: Adagio to Seek COVID-19 EUA, CytoDyn's Bad ...

Concentric Analgesics completed its Phase II trial of vocacapsaicin in patients undergoing open laparotomy for ventral hernia repair.

2022-03-30 - Concentric Analgesics Announces Positive Results from Pilot Phase ...

Concentric Analgesics is a clinical-stage, biopharmaceutical company focused on developing and commercializing novel, non-opioid pain...

2022-02-22 - Concentric Analgesics Announces Completion of $20 Million ...

Concentric Analgesics is a clinical-stage, biopharmaceutical company focused on developing and commercializing novel, non-opioid pain...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.6M376%N/A
#2
$6.9M3723%$21M
#3
$7.5M370%N/A
#4
$5.2M376%N/A
#5
$4.3M3712%N/A